Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $322.52 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $85.76 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $73.63 | 3 | $0 (2024) |
| ABBVIE INC. | $56.03 | 2 | $0 (2024) |
| PFIZER INC. | $34.14 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.35 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $24.33 | 1 | $0 (2022) |
| Boston Scientific Corporation | $22.28 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $213.51 | 9 | Novartis Pharmaceuticals Corporation ($85.76) |
| 2023 | $64.22 | 3 | ABBVIE INC. ($28.26) |
| 2022 | $44.79 | 2 | AstraZeneca Pharmaceuticals LP ($24.33) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2023 | Boston Scientific Corporation | AMS 800 Artificial Urinary Sphincter (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: AMS 800_URO | ||||||
| 03/22/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/13/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 21 | $10,899 | $1,289 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 21 | $10,899 | $1,289 | 11.8% |
About Kevin Lee, NURSE PRACTITIONER
Kevin Lee, NURSE PRACTITIONER is a Acute Care healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2022. The National Provider Identifier (NPI) number assigned to this provider is 1730830274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Lee, NURSE PRACTITIONER has received a total of $322.52 in payments from pharmaceutical and medical device companies, with $213.51 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($322.52).
As a Medicare-enrolled provider, Lee has provided services to 21 Medicare beneficiaries, totaling 21 services with total Medicare billing of $1,289. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Staten Island, NY
- Active Since 01/17/2022
- Last Updated 01/28/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1730830274
Products in Payments
- XARELTO (Drug) $73.63
- ENTRESTO (Drug) $60.03
- ELIQUIS (Drug) $34.14
- DALVANCE (Drug) $28.26
- AVYCAZ (Drug) $27.77
- JARDIANCE (Drug) $26.35
- LEQVIO (Drug) $25.73
- TAGRISSO (Drug) $24.33
- AMS 800 Artificial Urinary Sphincter (Device) $22.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Staten Island
Mrs. Amelia Tirado, N.p, N.P
Acute Care — Payments: $1,775
Ms. Jennifer Rizzi, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $1,131
Sandra Ollis
Acute Care — Payments: $902.27
Michelle Dorsey, Np, NP
Acute Care — Payments: $760.16
Candice Evans
Acute Care — Payments: $463.10
Krystelle Afif, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $364.62